• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

Comprehensive Overview of 1-(oxetan-3-yl)-1H-pyrazole-4-carboxylic acid (CAS No. 1389323-51-6)

1-(oxetan-3-yl)-1H-pyrazole-4-carboxylic acid (CAS No. 1389323-51-6) is a heterocyclic compound that has garnered significant attention in pharmaceutical and agrochemical research due to its unique structural features. The molecule combines an oxetane ring with a pyrazole-carboxylic acid moiety, making it a versatile intermediate for drug discovery and material science applications. Researchers are particularly interested in its potential as a bioisostere for improving drug solubility and metabolic stability.

The oxetane ring in 1-(oxetan-3-yl)-1H-pyrazole-4-carboxylic acid contributes to its three-dimensional character, which is highly valued in modern medicinal chemistry. This structural element can enhance binding affinity to biological targets while reducing molecular flexibility, a feature that aligns with current trends in fragment-based drug design. The carboxylic acid group provides an excellent handle for further derivatization, allowing chemists to create diverse analogs for structure-activity relationship studies.

Recent publications highlight the growing importance of 1-(oxetan-3-yl)-1H-pyrazole-4-carboxylic acid derivatives in developing kinase inhibitors and GPCR modulators. The compound's ability to serve as a hydrogen bond donor/acceptor makes it particularly valuable for targeting protein-protein interactions, a hot topic in cancer therapeutics and neurodegenerative disease research. Several pharmaceutical companies have included this scaffold in their high-throughput screening libraries.

From a synthetic chemistry perspective, 1-(oxetan-3-yl)-1H-pyrazole-4-carboxylic acid offers interesting challenges and opportunities. The oxetane ring stability under various reaction conditions has been extensively studied, with particular focus on its behavior in cross-coupling reactions and click chemistry applications. These studies are crucial for developing efficient synthetic routes to complex molecules containing this structural motif.

The compound's physicochemical properties have been characterized in detail, showing favorable logP values and aqueous solubility for drug discovery applications. These characteristics make 1-(oxetan-3-yl)-1H-pyrazole-4-carboxylic acid particularly attractive for developing oral bioavailability in small molecule therapeutics. Computational chemistry studies suggest interesting conformational preferences that may influence its biological activity.

In material science, derivatives of 1-(oxetan-3-yl)-1H-pyrazole-4-carboxylic acid have shown promise as building blocks for functional polymers and coordination complexes. The compound's ability to form stable metal chelates is being explored for applications in catalysis and sensor development. These interdisciplinary applications demonstrate the broad utility of this chemical scaffold beyond traditional pharmaceutical uses.

The commercial availability of 1-(oxetan-3-yl)-1H-pyrazole-4-carboxylic acid (CAS No. 1389323-51-6) has increased significantly in recent years, reflecting growing demand from both academic and industrial researchers. Suppliers typically offer the compound with various purity grades, including HPLC-grade material for biological testing. Current market analysis suggests steady growth in this niche chemical segment, driven by expanding applications in medicinal chemistry and material science.

Quality control protocols for 1-(oxetan-3-yl)-1H-pyrazole-4-carboxylic acid typically involve HPLC analysis, mass spectrometry, and NMR spectroscopy to ensure compound identity and purity. These analytical methods are crucial for researchers who require high-quality building blocks for their synthetic projects. The compound's stability under various storage conditions has been well-documented, with recommendations for optimal preservation.

Future research directions for 1-(oxetan-3-yl)-1H-pyrazole-4-carboxylic acid derivatives may include exploration of their photophysical properties for optoelectronic applications and further investigation of their biological activity profiles. The compound's structural features suggest potential for development as proteolysis targeting chimeras (PROTACs) or other emerging therapeutic modalities. These applications position this chemical scaffold at the forefront of modern chemical research.

For researchers working with 1-(oxetan-3-yl)-1H-pyrazole-4-carboxylic acid, proper handling procedures should be followed despite its non-hazardous classification. Standard laboratory practices including the use of personal protective equipment and proper ventilation are recommended when handling this compound or its derivatives. Material safety data sheets should always be consulted before beginning experimental work.

• 139308-53-5(Ethyl 1-tert-butyl-1H-pyrazole-4-carboxylate)
• 874196-91-5(1H-Pyrazole-4-carboxylic acid, 1-(2-methoxyethyl)-, ethyl ester)
• 874196-94-8(1-(2-methoxyethyl)-1H-Pyrazole-4-carboxylic acid)
• 950858-65-8(1-Tert-butyl-1H-pyrazole-4-carboxylic acid)
• 400858-54-0(1-Ethyl-1H-pyrazole-4-carboxylic acid)
• 1006469-47-1(1-(2-Hydroxyethyl)-1H-pyrazole-4-carboxylic acid)
• 1343835-81-3(1-(oxolan-3-yl)-1H-pyrazole-4-carboxylic acid)
• 1622883-44-6(1-Cyclopropyl-1H-pyrazole-4-carboxylic acid)
• 304693-70-7(1-(2-methoxyethyl)pyrazole-4-carbaldehyde)
• 436096-96-7(1-(propan-2-yl)-1H-pyrazole-4-carboxylic acid)